ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
A person working from a basement used artificial intelligence to create a drug candidate for Alzheimer's disease. The AI-driven approach identified a potential treatment without traditional laboratory infrastructure. The drug targets the underlying mechanisms of Alzheimer's, offering a new avenue for therapy development.
Tap to vote and see what everyone thinks.
Summary by ByteBrief